Delivery Order SPE2DB24D1104-SPE2DB25FYDP9
- Not listed
- The Defense Logistics Agency awarded a $11.9K delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampul 2.5mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pulmozyme 1 mg/mL ampules (2.5 mL) at a ceiling value of $6,286.98. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor. The performance location is...
- The Defense Logistics Agency awarded a $49,798.78 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampul 2.5ml pharmaceutical products. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing...
- This is a $27,880.43 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has an ultimate completion date of September 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5ml units) with a ceiling value of $3,644.71 under a firm fixed-price contract. This delivery order represents a non-set-aside competitive award and is child to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $2,583.60 delivery order to AmerisourceBergen Drug Corp for PULMOZYME 1 mg/ml ampules (2.5 ml units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL pharmaceutical product. This is a firm fixed price delivery order with a ceiling value of $2,583.60 and an ultimate completion date of July 28, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance to be executed at the vendor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $7,100 to Amerisourcebergen Drug Corporation for the supply of 4561860956 Pulmozyme 1 MG/ML ampules. The delivery order, issued under an unspecified governmentwide acquisition contract, calls for Amerisourcebergen to deliver 2.5mL ampules of the respiratory drug Pulmozyme to a location in Conshohocken, Pennsylvania by August 21, 2023. No subcontractors or set-aside...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $11,864.81 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampules. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $8,541.31 to Amerisourcebergen Drug Corporation for the provision of 4561966068 Pulmozyme 1 MG/ML ampules. Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 29, 2023 in fulfillment of this order issued under an existing DLA contract vehicle. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDP9Delivery Order
The Defense Logistics Agency awarded a $9.68K delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampules (2.5 mL units) on July 23, 2025, with completion expected by July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive federal contract portfolio with DLA demonstrates its capability to meet competitive procurement requirements and supply diverse pharmaceutical products to support military healthcare systems, the Defense Health Agency, and other government agencies. Pulmozyme is a cystic fibrosis treatment, representing the type of specialized pharmaceutical product the contractor routinely delivers through its IDC vehicle to support military medical missions globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 7/23/25 |